GoKawiilRed Queen Bio Develops AI Antibody Drugs to Preempt Engineered Pathogens
Startup Red Queen Bio is applying artificial intelligence to design antibody treatments aimed at novel pathogens. The company frames its work as preparation against future biological threats that could themselves be engineered using AI tools.